DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA)

被引:0
|
作者
MORELAND, LW
SEWELL, KL
SULLIVAN, WF
SHMERLING, RH
PARKER, KC
SWARTZ, WG
WOODWORTH, TG
TRENTHAM, DE
KOOPMAN, WJ
机构
[1] UNIV ALABAMA,BIRMINGHAM,AL 35294
[2] BETH ISRAEL HOSP,BOSTON,MA 02215
[3] SERAGEN INC,HOPKINTON,MA
来源
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S39 / S39
页数:1
相关论文
共 50 条
  • [21] TREATMENT OF RHEUMATOID-ARTHRITIS WITH L-HISTIDINE - RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    PINALS, RS
    HARRIS, ED
    BURNETT, JB
    GERBER, DA
    JOURNAL OF RHEUMATOLOGY, 1977, 4 (04) : 414 - 419
  • [22] PHASE-I TRIAL OF A 90-MINUTE INFUSION OF THE FUSION TOXIN DAB486IL-2 IN HEMATOLOGICAL CANCERS
    LEMAISTRE, CF
    CRAIG, FE
    MENEGHETTI, C
    MCMULLIN, B
    PARKER, K
    REUBEN, J
    BOLDT, DH
    ROSENBLUM, M
    WOODWORTH, T
    CANCER RESEARCH, 1993, 53 (17) : 3930 - 3934
  • [23] A double-blind, randomised, placebo-controlled trial of anti-interleukin-6 (IL-6) receptor monoclonal antibody in rheumatoid arthritis (RA).
    Choy, EH
    Isenberg, DA
    Farrow, S
    Garrood, T
    Ioannou, Y
    Bird, HA
    Cheung, N
    Williams, BD
    Hazleman, B
    Price, R
    Kishimoto, T
    Panayi, GS
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S274 - S274
  • [24] A Double-Blind Randomized Placebo-Controlled Trial Of Lovastatin in Patients with Rheumatoid Arthritis.
    Aranow, Cynthia
    Cush, John J.
    Bolster, Marcy B.
    Striebich, Christopher C.
    Dall'Era, Maria
    Mackay, Meggan
    Olech, Ewa
    Frech, Tracy M.
    Box, J.
    Keating, Richard M.
    Wasko, Mary Chester M.
    St Clair, E. William
    Kivitz, Alan
    Diamond, Betty
    Davidson, Anne
    Spychala, Meagan
    Goldmuntz, Ellen A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1181 - S1182
  • [25] TREATMENT OF RHEUMATOID-ARTHRITIS WITH ORAL COLLAGEN TYPE-II - RESULTS OF A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED TRIAL
    SIEPER, J
    KARY, S
    EGGENS, U
    ZINK, A
    MITCHISON, NA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 957 - 957
  • [26] RHEUMAJECTA AND VASOLASTINE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - THE RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF A COMPLEMENTARY TREATMENT
    JACOBS, JWG
    RASKER, JJ
    VANRIEL, PLCM
    GRIBNAU, FWJ
    VANDEPUTTE, LBA
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (06) : 434 - 440
  • [27] DISCONTINUING 2ND-LINE DRUGS IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) IN REMISSION - A 52-WEEK DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    WOLDE, S
    BREEDVELD, FC
    HERMANS, J
    VANDENBROUCKE, JP
    VANDELAAR, MAFJ
    MARKUSSE, HM
    JANSSEN, M
    VANDENBRINK, HR
    DIJKMANS, BAC
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 207 - 207
  • [28] Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
    Vergunst, Clarissa E.
    Gerlag, Danielle M.
    Lopatinskaya, Luba
    Klareskog, L.
    Smith, M. D.
    van den Bosch, F.
    Dinant, Huib J.
    Lee, Yih
    Wyant, Timothy
    Jacobson, Eric W.
    Baeten, Dominique
    Tak, Paul P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (07): : 1931 - 1939
  • [29] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
    Xiaoying Zhang
    Miao Miao
    Ruijun Zhang
    Xu Liu
    Xiaozhen Zhao
    Miao Shao
    Tian Liu
    Yuebo Jin
    Jiali Chen
    Huixin Liu
    Xia Zhang
    Yun Li
    Yunshan Zhou
    Yue Yang
    Ru Li
    Haihong Yao
    Yanying Liu
    Chun Li
    Yuhui Li
    Limin Ren
    Yin Su
    Xiaolin Sun
    Jing He
    Zhanguo Li
    Signal Transduction and Targeted Therapy, 7
  • [30] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
    Zhang, Xiaoying
    Miao, Miao
    Zhang, Ruijun
    Liu, Xu
    Zhao, Xiaozhen
    Shao, Miao
    Liu, Tian
    Jin, Yuebo
    Chen, Jiali
    Liu, Huixin
    Zhang, Xia
    Li, Yun
    Zhou, Yunshan
    Yang, Yue
    Li, Ru
    Yao, Haihong
    Liu, Yanying
    Li, Chun
    Li, Yuhui
    Ren, Limin
    Su, Yin
    Sun, Xiaolin
    He, Jing
    Li, Zhanguo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)